Susan Altschuller

Susan Altschuller is currently Director at Vestaron Corp., Founding Member at HNRNP Family Foundation, and Treasurer, Chief Financial & Accounting Officer at Climb Bio, Inc. Former roles include Independent Director at Mural Oncology Plc, Head-Investor Relations at Biogen, Inc., Head-Enterprise Finance at Alexion Pharmaceuticals, Inc., Chief Financial Officer at Dragonfly Therapeutics, Inc., Head-Investor Relations at Bioverativ, Inc., Chief Financial Officer & Senior Vice President at ImmunoGen, Inc., and Chief Financial Officer at Cerevel Therapeutics Holdings, Inc. and Cerevel Therapeutics, Inc. Education includes a doctorate from Illinois Institute of Technology, an undergraduate degree from Tulane University (Louisiana), and an MBA from MIT Sloan School of Management.